“With imports comprising as much as 70 to 90 percent of drugs consumed in most countries in sub-Saharan Africa, many governments are considering whether it’s time to promote more local production. Drug imports, including both over-the-counter and prescription drugs, do considerably exceed those into China and India – where comparable populations import around 5 percent and 20 percent, respectively. And it does put a strain on government and household budgets and already limited foreign exchanges.”
– McKinsey
Manufacturer
CEO and President of Kiara Health (Pty) Ltd, Dr Skhumbuzo Ngozwana, explains how the SAP S/4HANA now forms a solid foundation to enable Kiara Health to securely monitor Production, Quality and Supply Chain operations.
At a Glance
Kiara Health is a SAHPRA licensed pharmaceutical manufacturing company, importer and marketer of pharmaceutical products and medical technologies (the latter under sister company, Kiara MedTech).
We have acquired 26 Marketing Authorisations (marketed) and a world-class pharmaceutical manufacturing plant and personnel from Sandoz, the generic subsidiary of Swiss multinational pharmaceutical company Novartis, in 2019.
At Kiara Health, we manufacture our own pharmaceutical products and offer customised manufacturing services for local and international pharmaceutical companies.
OTIF scores > 95%
Site close to OR Tambo International Airport:
- The gateway to easy access into the rest of the African continent.
- Reduced cost to transport your goods for air freighting.
- GMP Certified
- High quality standards and focused on continuous improvement
Manufacturing
Primary and Secondary Packaging
Quality Control Testing Services
Stability Services
Quality Assurance throughout the QMS
Post Importation Testing
Warehousing
Cold Storage
Manufacturing
The Kiara Health Manufacturing site has the capability to produce its own Marketing Authorised products as well as CMO.
Key manufacturing types:
- Capsules
- Tablets
- Sugar-coating
- Film-coating
Key Process Technologies:
Dry mixing, wet granulation, encapsulation, compression and coating (film-coated and sugar-coated).
Packaging
PRIMARY PACKAGING:
- Blister
- Tablets
- Capsules
- Securitainer
- Tablets
- Capsules
SECONDARY PACKAGING:
Contract packaging
Effervescent tablets, tablets/capsules, (polyvinyl chloride (PVC) / polyvinylidene chloride (PVDC) blisters, bottles) nasal sprays, eye drops, suppositories and ampoules/vials for injection/ infusion.
Quality Assurance
The Kiara Health Quality Assurance team is responsible for defining and executing systems and processes across the company that ensure that goods and services meet all quality, efficacy, and safety requirements. The Team is intricately involved to ensure that the highest quality standards for the following are met:
- New Product Planning
- Design
- Prototype Creation
- Testing
- Subcontracting
- Purchasing
- Process Design
- Trial Production
- Production
- Marketing
- Distribution
- After-Sales Service
Post Importation Testing
- Capacity for ID and Assay Post Importation Testing on Solid Dosage forms.
- Dedicated and highly skilled Analytical Science and Technology Team for Method Development and Transfer.
Stability Programme Services
- Stability Programme Hosting for stability zones:
- 25°Celsius /60% RH
- 30°Celsius / 65% RH
- 40°Celsius /75% RH
- Accelerated and Follow Up Stability (FUST) programmes.
- Stability Chambers linked to online EMS system.
Warehousing
- Total warehousing capacity of 2,181 m2 .
- Warehousing capacity available for 3,000 pallets.
- Secure areas available to store and distribute Controlled substances.
- Environmental monitored warehouse; linked to online EMS system.
- Control and monitoring of temperature; humidity is monitored.
Cold Chain Storage
- 2 – 8°Celsius
- Capacity: 300 pallets
